Although Philadelphia-positive ALL (Ph+) patients are typically characterized by BCR::ABL1 fusion, the use of NGS has demonstrated that the genomic and transcriptomic profiles can be heterogeneous. The gene discussed is ABL1; the disease is acute lymphoblastic leukemia.